Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia.
about
Advances in haplo-identical stem cell transplantation in adults with high-risk hematological malignanciesHematopoietic stem cell allografting for chronic lymphocytic leukemia: a focus on reduced-intensity conditioning regimensT Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical OutcomeSerologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens.Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusion.Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia.Bispecific antibodies engage T cells for antitumor immunotherapy.The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC.Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation.Adoptive T cell therapy of cancer.Novel myeloma-associated antigens revealed in the context of syngeneic hematopoietic stem cell transplantation.Generation of allo-restricted peptide-specific T cells using RNA-pulsed dendritic cells: A three phase experimental procedureImmunotherapy of Metastatic Colorectal Cancer: Prevailing Challenges and New Perspectives.Treatment options for high-risk chronic lymphocytic leukaemia.Autologous CLL cell vaccination early after transplant induces leukemia-specific T cellsAdoptive T-cell therapy for B-cell malignancies.The role of dendritic cells in graft-versus-tumor effectEngineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia.Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival.Personalizing Stem Cell Research and Therapy: The Arduous Road Ahead or Missed Opportunity?Patient-individualized CD8⁺ cytolytic T-cell therapy effectively combats minimal residual leukemia in immunodeficient mice.
P2860
Q27014857-CD3689C0-74D6-4863-AAAB-8153FFDD28D0Q27021206-CB60D48A-20C3-45BE-8CDE-FFF8734C7DB0Q28072227-C0FB3643-869F-4539-B5DF-1B7A710D13FEQ33779931-B3E6517D-4DDD-484E-940F-381B89068603Q33857800-5CDA73F7-9813-4CCB-BDA9-F3CDDF965DC6Q33917224-A2991FF8-3CDC-452F-88A8-484F9F80A1D9Q34174334-5C10D12E-191C-4397-9F6A-4FEBEC9FF37FQ34374056-CE1F9998-D148-4CE2-A254-DC4ADDC0D573Q34531834-9C672553-B7E5-4736-8708-0598F0D90336Q34771143-3027946C-D1CE-4192-B9BD-DA14A8B96737Q34977470-C27B5715-7854-48FF-9AF9-308EC67B0FCEQ35877000-166D1631-E8EC-4847-B0DB-35DC207788BAQ36038463-7710EA5C-E73A-41AA-82A3-4F1BC0237AC8Q36114649-698E61F8-7C6E-4C59-8A81-BF43800855A6Q36612587-129B6667-5908-478E-B789-EAB0EB89BAA9Q37123927-DDBDF5A0-BFB6-410C-85B6-D2A9793DE175Q37810116-5958D704-1F45-4F3E-8D98-AF1584A89AE8Q38193807-603DEB97-C47C-4C68-91B9-99167B672661Q39718346-A2A17543-AEE7-4128-AAF0-68F124C1D81AQ40291708-0D120A00-4D11-4F9A-B25B-DF99BE6F0881Q41122141-FBED466F-5D42-40E7-B67D-35742EDF87BEQ50708752-A4539CD9-D571-4CFF-9BF5-7F8B37A052EB
P2860
Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of tumor-reactive ...... chronic lymphocytic leukemia.
@en
Development of tumor-reactive ...... chronic lymphocytic leukemia.
@nl
type
label
Development of tumor-reactive ...... chronic lymphocytic leukemia.
@en
Development of tumor-reactive ...... chronic lymphocytic leukemia.
@nl
prefLabel
Development of tumor-reactive ...... chronic lymphocytic leukemia.
@en
Development of tumor-reactive ...... chronic lymphocytic leukemia.
@nl
P2093
P2860
P1476
Development of tumor-reactive ...... chronic lymphocytic leukemia.
@en
P2093
Ana Kostic
Edus H Warren
Marie Bleakley
Michael Hudecek
Stanley R Riddell
Tetsuya Nishida
P2860
P304
P356
10.1158/1078-0432.CCR-09-0199
P407
P577
2009-06-30T00:00:00Z